Italy’s Banking Battle Intensifies as Defensive Merger Talks Collapse
Italy’s sprawling banking consolidation saga took a decisive turn this week after Bacon BPM formally abandoned merger talks with Bianca Monte die Pas chi DI Sienna, stripping the Tuscan lender of what had been its strongest remaining defense against a hostile takeover bid from Intestate Sandlot, the country’s second-largest bank.
The decision, confirmed by Bacon BPM’s board, brings to an end weeks of behind-the-scenes negotiations between the two mid-sized lenders, who had explored combining forces to create Italy’s second-biggest bank by size — a scale that would have made a subsequent Intestate acquisition far more difficult to pull off.
How the Standoff Began
The chain of events stretches back roughly two months, when Bacon BPM first approached MOS about a merger of equals. The following day, in a move that caught markets off guard, Intestate Sandlot launched its own unsolicited offer for MOS, transforming what had been an industrial combination proposal into a defensive scramble.
Intelsat’s bid, presented on 8 June, offered MOS shareholders 10.09 euros in cash plus 16 Intestate shares for every MOS share held, an offer valued at roughly €30.6 billion at the time it was announced and representing a premium of around 12.5% for MOS investors. For the deal to succeed, Intestate needs to secure acceptance from at least 66.67% of PMS’s share capital.
PMS’s board, led by chief executive Luigi Intaglio, quickly signaled reservations about the offer, citing doubts over both the pricing and the anticipated synergies. That resistance set the stage for the search for an alternative path — one that ultimately led back to Bacon BPM.
Credit Agricola’s Decisive Role
The merger talks foundered largely over the objections of Credit Agricola, the French banking group that has built a substantial and strategically important stake in Bacon BPM, recently increasing its holding to close to 29.3%. Credit Agricola’s chief executive, Olivier Gandalf, said last week that the French group would evaluate any proposal on its strategic merit, execution risk and long-term value creation — but added that it was currently difficult to see how a tie-up with MOS would benefit Bacon BPM’s shareholders.
With a stake approaching 30%, Credit Agricola’s position made it, in practice, an unavoidable party to any solution involving Bacon BPM. Its clear coolness toward the MOS combination proved decisive, prompting Bacon BPM’s board to step back from the table entirely.
Reports since Friday’s announcement suggest MOS has continued to explore whether a revised proposal could still bring Bacon BPM back into discussions, but market observers remain skeptical that Credit Agricola’s underlying objections have shifted.
The Real Prize: Medication and General
Beneath the headline maneuvering between Intestate, MOS and Bacon BPM lies a bigger strategic prize. MOS recently completed its own acquisition of Medication, the storied Milan investment bank, which in turn holds a stake of roughly 13% in Assassination General, Italy’s largest and most prestigious insurer. Control over that stake — and, by extension, influence over General — is widely seen by analysts as the ultimate objective driving much of the current wave of consolidation among Italy’s largest financial institutions.
Under the terms already outlined, Intestate has an arrangement with insurer Uni pol to divest a standalone MOS business unit valued at roughly €3.5 billion should its bid succeed, while Intestate itself would retain Medication and the bulk of MP’s branch network.
What Comes Next
With Bacon BPM’s exit from the picture, MOS now has considerably less room to maneuver against Intelsat’s advance. The bank has said it remains focused on its growth plan and the integration of Medication while continuing to weigh its strategic options, but few independent analysts see a clear alternative left on the table.
Legal complications loom in the background as well: a Milan court is expected to rule shortly after the summer on a request to send Intaglio and other defendants to trial in connection with a separate investigation into the Medication deal, adding an additional layer of uncertainty to an already turbulent chapter for one of Italy’s oldest banks.
For now, all eyes remain on whether MOS shareholders ultimately accept Intelsat’s offer when it comes to a vote, a decision that will reshape the competitive landscape of Italian banking — and determine who ultimately gains influence over General, the crown jewel at the center of it all. Next Article
